Landmark editorial denounces 'poor publication practices' in spine research

Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product.

The unusually blunt editorial in The Spine Journal notes that in 13 trials involving 780 patients, industry-funded researchers did not report a single adverse advent involving Medtronic's Infuse Bone Graft. (The product, approved for certain surgeries, is designed to eliminate the need to harvest bone from the hip.)

The editorial in the nation's leading spine journal notes that the authors of nearly all the trials had financial ties with the manufacturer, with investigators earning as much as $26 million per study.

However, subsequent studies have documented , including inflammatory reactions, cancer, infection and implant dislodgement.

Flawed clinical research of the product and inadequate dislcosure of industry relationships are examples of the problems arising from financial ties between physicians and the medical device and .

"We find ourselves at a precarious intersection of professionalism, morality and public safety," the editorial states. "We work under a burden of suspicion that new technology research and publication is simply a 'broken system' as currently practiced. Our professionalism... is fundamentally challenged by the threat of 'tainted science.'"

The editorial goes on: "It harms patients to have biased and corrupted research published. It harms patients to have unaccountable special interests permeate medical research. It harms patients when poor publication practices become business as usual."

Researchers who have to industry often say they have too much integrity to allow industry funding to affect their objectivity. The editorial says this "choirboy defense" lacks even minimum credibility.

"Instead the press and public assume that multimillion-dollar compensation packages can and do alter the balance of objectivity."

add to favorites email to friend print save as pdf

Related Stories

Study: Riskier surgeries for back pain raise costs

Apr 06, 2010

(AP) -- A study of Medicare patients shows that costlier, more complex spinal fusion surgeries are on the rise - and sometimes done unnecessarily - for a common lower back condition caused by aging and arthritis.

Complications rise along with off-label use of BMP-2

Sep 06, 2010

When the U.S. Food and Drug Administration in 2002 approved a product many thought would revolutionize back surgery, the agency did so despite concerns the product might cause serious side effects.

Recommended for you

Exploring 3-D printing to make organs for transplants

21 hours ago

Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients ...

High frequency of potential entrapment gaps in hospital beds

23 hours ago

A survey of beds within a large teaching hospital in Ireland has shown than many of them did not comply with dimensional standards put in place to minimise the risk of entrapment. The report, published online in the journal ...

Key element of CPR missing from guidelines

Jul 29, 2014

Removing the head tilt/chin lift component of rescue breaths from the latest cardiopulmonary resuscitation (CPR) guidelines could be a mistake, according to Queen's University professor Anthony Ho.

Burnout impacts transplant surgeons (w/ Video)

Jul 28, 2014

Despite saving thousands of lives yearly, nearly half of organ transplant surgeons report a low sense of personal accomplishment and 40% feel emotionally exhausted, according to a new national study on transplant surgeon ...

User comments